H-L-Tyr(All)-OMe*HCl

L-Histidine-L-Tyrosine(All)-OMe*HCl is a protected amino acid ester salt featuring an L-tyrosine-derived chiral center and a tyrosine side chain bearing an All-type phenolic protection group, along with an O-methyl ester masked as the corresponding methyl ester hydrochloride. The structure combines a stereodefined amino acid backbone with a protected phenol and an ester carbonyl, creating a controlled reactivity profile for peptide coupling chemistry while suppressing undesired side reactions from the phenolic hydroxyl. The hydrochloride counterion improves handling of the amino ester salt and can support downstream transformations that require well-defined, isolable intermediates. The All-protected phenol and the ester functionality together enable stepwise deprotection and conversion into amide-linked peptide building blocks or functionalized tyrosine derivatives under standard amino acid synthesis conditions.

1. Peptide Synthesis

L-Histidine-L-Tyrosine(All)-OMe*HCl is used in peptide building block preparation where the amino acid ester format supports coupling strategies that generate amide bonds at the tyrosine α-position. The protected phenolic side chain reduces competing O-acylation during peptide coupling, while the defined stereochemistry at the α-carbon helps maintain sequence fidelity in tyrosine-containing segments. The methyl ester can be transformed into activated carboxyl equivalents for iterative chain extension or converted into a free acid prior to final assembly, enabling controlled N- and C-terminal manipulation. Stepwise deprotection of the All group can then reveal the tyrosine phenol for subsequent conjugation, crosslinking, or further derivatization in peptide science and peptidomimetic construction.

2. Side-Chain Functionalization

L-Histidine-L-Tyrosine(All)-OMe*HCl is relevant to side-chain functionalization workflows that target the tyrosine phenolic handle after orthogonal protection management. The All-protected phenol allows the molecule to be carried through peptide coupling or intermediate synthesis steps without phenoxide-driven side reactions, while the ester carbonyl provides a handle for conversion to acids, amides, or other downstream derivatives. After controlled deprotection, the liberated tyrosine phenol can participate in selective etherification, esterification, or electrophilic aromatic substitution to install linkers, labels, or reactive moieties. This enables downstream generation of tyrosine-functionalized amino acid derivatives and peptide analogs used for chemical biology probes, biochemical assays, and structure-driven scaffold modification.

3. Chemical Biology Probes

L-Histidine-L-Tyrosine(All)-OMe*HCl is applicable to chemical biology research that requires tyrosine-containing motifs for molecular recognition studies and functional labeling. The combination of a stereodefined amino acid backbone and a protected phenol supports incorporation into peptide fragments that can later be unmasked to provide a phenolic group for conjugation chemistry. The methyl ester hydrochloride form can be used as a stable intermediate for assembling probe precursors, including peptide-based scaffolds that are subsequently functionalized with tags, affinity handles, or reactive groups compatible with biomolecule labeling. Downstream derivatization can yield tyrosine-bearing conjugates for studying binding interactions, mapping post-synthetic modifications, or constructing well-defined peptidic reagents for biochemical investigations.

4. Protected Amino Acid Chemistry

L-Histidine-L-Tyrosine(All)-OMe*HCl is suited to protected amino acid synthesis and protecting-group strategy development because it integrates an orthogonally protected tyrosine side chain with an amino acid ester functionality. The All-type phenol protection enables orthogonal deprotection planning relative to other protecting groups that may be present on neighboring residues during multi-step peptide assembly. The α-amino functionality in the salt/ester form supports controlled activation and coupling sequences, while the ester group can be selectively hydrolyzed or transformed to meet the requirements of specific peptide synthesis routes. This makes the compound useful as a chiral amino acid intermediate for preparing tyrosine-containing building blocks, enabling reproducible construction of peptide fragments and facilitating process-compatible intermediate handling in fine chemical synthesis.

5. Pharmaceutical Manufacturing Intermediates

L-Histidine-L-Tyrosine(All)-OMe*HCl can be incorporated into manufacturing-oriented workflows for peptide and peptide-like intermediates where orthogonal protection and controlled functional group exposure are required. The protected tyrosine phenol helps prevent side reactions during chain assembly, while the methyl ester can serve as a controllable carboxyl equivalent during intermediate fabrication before conversion to the corresponding acid or activated derivative. The defined stereochemistry at the amino acid center supports consistent quality of peptide building blocks used in upstream synthesis of sequence-defined products. Downstream processing may involve deprotection to expose the tyrosine phenol for final conjugation steps or for generating standardized intermediates used in industrial peptide science and specialty chemical production.

1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

2. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines